Feasibility and safety of outpatient hypomethylating agent and venetoclax initiation with and without ramp-up for newly diagnosed acute myeloid leukemia: results from the Consortium on Myeloid Malignancies and Neoplastic Diseases (COMMAND)
Leukemia & Lymphoma | April 28, 2025 | Volume: 66 | Issue: 9 | Pages: 1735-1739
10.1080/10428194.2025.2496339
| PMID 40294060